A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.
Jing H, Hu J, He B, Negron Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H
Cancer Cell. 2016 Mar 14;29(3):297-310. doi: 10.1016/j.ccell.2016.02.007. PubMed Article
Jing H, Hu J, He B, Negron Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H
Cancer Cell. 2016 Mar 14;29(3):297-310. doi: 10.1016/j.ccell.2016.02.007. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 102622 | pET28a-6XHis-SUMO-SIRT2 | Expresses a truncation (aa38-356) of human SIRT2 isoform 1 in bacteria for purification |
| 102623 | pCMV4a-SIRT2-Flag | Expresses full length SIRT2 isoform 1 in mammalian cells |
| 102624 | pCDH-SIRT2-Flag | Expresses full length SIRT2 isoform 1 in mammalian cells |
| 102625 | pCMV4a-Flag-c-Myc | Expresses c-Myc in mammalian cells |
| 102626 | pCDH-Flag-c-Myc | Expresses c-Myc in mammalian cells |